An International Phase III Randomised Study to Evaluate the Efficacy of MTCE CEDIRANIB and OLAPARIB Combination Therapy or OLAPANB Alone in Patients with Relapsed Platinum-sensitive Ovarian Cancer Following a Response to Platinum-based Chemotherapy (ICON9)

Project Member(s): Viney, R., De Abreu Lourenco, R., Vargas Parada, C.

Funding or Partner Organisation: Cancer Research UK
Cancer Research UK

Start year: 2018

FOR Codes: Health Economics, Health Policy Economic Outcomes, Health economics , Health policy evaluation, Evaluation of health and support services not elsewhere classified

Acknowledgement of Country

UTS acknowledges the Gadigal people of the Eora Nation, the Boorooberongal people of the Dharug Nation, the Bidiagal people and the Gamaygal people, upon whose ancestral lands our university stands. We would also like to pay respect to the Elders both past and present, acknowledging them as the traditional custodians of knowledge for these lands.